Cargando…
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247433/ https://www.ncbi.nlm.nih.gov/pubmed/32450915 http://dx.doi.org/10.1186/s13063-020-04407-x |
| _version_ | 1783538152882831360 |
|---|---|
| author | Feeney, Eoin Wallace, Deborah Cotter, Aoife Tinago, Willard McCarthy, Cormac Keane, David Hussain, Rabia Alvarez Barco, Elena Doran, Peter Mallon, Patrick |
| author_facet | Feeney, Eoin Wallace, Deborah Cotter, Aoife Tinago, Willard McCarthy, Cormac Keane, David Hussain, Rabia Alvarez Barco, Elena Doran, Peter Mallon, Patrick |
| author_sort | Feeney, Eoin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7247433 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72474332020-05-26 The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial Feeney, Eoin Wallace, Deborah Cotter, Aoife Tinago, Willard McCarthy, Cormac Keane, David Hussain, Rabia Alvarez Barco, Elena Doran, Peter Mallon, Patrick Trials Letter BioMed Central 2020-05-25 /pmc/articles/PMC7247433/ /pubmed/32450915 http://dx.doi.org/10.1186/s13063-020-04407-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter Feeney, Eoin Wallace, Deborah Cotter, Aoife Tinago, Willard McCarthy, Cormac Keane, David Hussain, Rabia Alvarez Barco, Elena Doran, Peter Mallon, Patrick The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_full | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_fullStr | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_full_unstemmed | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_short | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_sort | covirl-001 trial: a multicentre, prospective, randomised trial comparing standard of care (soc) alone, soc plus hydroxychloroquine monotherapy or soc plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, sars-cov-2 pcr-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: a structured summary of a study protocol for a randomised controlled trial |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247433/ https://www.ncbi.nlm.nih.gov/pubmed/32450915 http://dx.doi.org/10.1186/s13063-020-04407-x |
| work_keys_str_mv | AT feeneyeoin thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT wallacedeborah thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT cotteraoife thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT tinagowillard thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT mccarthycormac thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT keanedavid thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT hussainrabia thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT alvarezbarcoelena thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT doranpeter thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT mallonpatrick thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT feeneyeoin covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT wallacedeborah covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT cotteraoife covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT tinagowillard covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT mccarthycormac covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT keanedavid covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT hussainrabia covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT alvarezbarcoelena covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT doranpeter covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT mallonpatrick covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres |